Navigation Links
OmniSonics Appoints J. Daniel Cole Chairman of the Board
Date:9/24/2007

WILMINGTON, Mass., Sept. 24 /PRNewswire/ -- OmniSonics Medical Technologies, Inc., a leading developer of advanced medical devices for occlusive vascular disease, today announced the appointment of J. Daniel Cole as the company's new Chairman of the Board.

Mr. Cole is a founding partner with Spray Venture Partners, a venture capital firm that focuses exclusively on emerging healthcare technology companies. He brings twenty years of medical device operational experience, having served on the boards of 10 companies, two of which he started. Prior to joining Spray, Mr. Cole served as senior vice president and group president of Boston Scientific Corporation's (BSC) vascular business, a $1.2 billion group, and was also responsible for BSC's international operations. Prior to BSC, he was president and chief iperating officer of SCIMED Life Systems before the company's merger with Boston Scientific. He also held a variety of executive and general management positions at Baxter Healthcare. He currently serves on the Board of Directors of Acorn Cardiovascular, Tryton Medical, Direct Flow Medical, and Tremont Medical, and is actively involved in Kolis Scientific, PneumRx, and Thoratec Laboratories.

"We are thrilled to have Dan Cole as our new Chairman of the Board for OmniSonics," said Richard Ganz, president and CEO, OmniSonics Medical Technologies. "Over the last few years, we have been actively building a world-class team with in-depth experience in product development and commercialization. Dan's experience and leadership will be a major asset as we launch our products for vascular occlusive disease and build a word-class commercial enterprise."

"This is an exciting time to join the OmniSonics team," said J. Daniel Cole, Chairman of the Board and partner at Spray Venture Partners. "The company has assembled a management team with over 80 cumulative years of experience in medical devices and commercial operations. They have developed breakthrough
'/>"/>

SOURCE OmniSonics Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 26, 2015 Research ... the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. ... diagnostics technologies that will play an important ... pharmaceutical industry, forensics and biological warfare in ...
(Date:5/27/2015)... Brain Canada and the Ontario Brain Institute ... and multi-provincial research teams across Canada to address unmet ... initiative. To this amount, $1.5M is added from the ... announcement was made today at the annual meeting of ... Inez Jabalpurwala, President and CEO of Brain Canada ...
(Date:5/27/2015)... SAN FRANCISCO, Calif. , May 27, 2015 ... for the treatment of cancer, today announced the ... financial officer and Cynthia Ladd as ... joining CytomX, Goeltz was chief financial officer of ... served as an independent consultant and legal counsel ...
(Date:5/27/2015)... 27, 2015  US-Australian drug discovery and development company, Novogen ... it will present at the Brain Tumor Biotech Summit 2015, ... May 29, 2015. The venue is the Lennox Hill Hospital, ... The Brain Tumor Biotech Summit brings together ... and the investment community to promote innovative new therapies for ...
Breaking Biology Technology:Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 2Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 3Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 2Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 3Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 4Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 5Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 6Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 7Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 8Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 9Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 10CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3Novogen to Present at Brain Tumor Biotech Summit 2015 2Novogen to Present at Brain Tumor Biotech Summit 2015 3Novogen to Present at Brain Tumor Biotech Summit 2015 4Novogen to Present at Brain Tumor Biotech Summit 2015 5
... , , , ... SQNM ) and GeneWorks Pty. Ltd. today announced ... SEQUENOM in expanding its sales & marketing presence in Australia. ... across Australia. GeneWorks has significant experience and a strong reputation ...
... NEW YORK, Sept. 9 Future Pharmaceuticals features ... Manager of Informatics at Thermo Fisher Scientific, and Thor-Gunnar Steinsli, ... Biobank, about data integration: the benefits of data, instrument and ... , , "One of the biggest ...
... CHARLOTTESVILLE, Virginia, September 9 Biovista Inc.,today announced ... significant positive results in the MOG-induced Experimental Allergic,Encephalomyelitis (EAE) ... that,Biovista repositioned in MS and is aimed at neuroprotection. ... and no toxic effects in this well,established model of ...
Cached Biology Technology:SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia 2SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia 3SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia 4Don't Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation in IT, Cell-Based Therapy and Supply Chains 2Biovista Inc. Announces Positive Efficacy Results in a Pre-clinical Trial of its BVA-201 Repositioned Drug for Multiple Sclerosis 2
(Date:5/25/2015)... SYDNEY , May 25, 2015  Australia,s market ... inception stage, although 2014 saw the advent of several ... on 24 April 2015 is expected to ignite interest ... devices in Australia . This in ... the industry and drive new partnerships amongst vendors and ...
(Date:5/22/2015)... , May 22, 2015 According ... by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, ... (Government and Utilities, Consumer and Home) - Global Forecast ... grow from $2.77 Billion in 2015 to $6.19 Billion ... Browse 79 market data Tables and   43 ...
(Date:5/21/2015)... The Sync Project™ , a global ... today announced a collaborative partnership with Berklee,s Institute ... on collaboration on original research, joint course development and ... collaboration, The Sync Project and BerkleeICE are exploring the ... the 2015-2016 academic year.  The course ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... A research group led by a New York University School ... fish in the Hudson River to live in waters heavily ... 18, 2011, online issue of Science , they report ... in response to the toxic chemicals, which were first introduced ...
... research has found that a statin drug that is often ... people with diabetes. In a study using diabetic ... of Georgia College of Pharmacy, and her colleagues found that ... important to maintaining vision. The results of the study are ...
... (IOF) in its 2009 publication, ,The Asian Audit, it ... all osteoporotic fractures will occur in Asia. To meet ... need for advanced clinical training of health professionals as ... osteoporosis and related bone disorders within the Asia-Pacific region. ...
Cached Biology News:A genetic mutation allows Hudson River fish to adapt to PCBs 2Study suggests statins may prevent diabetic-related blindness 2
One-step, microplate or cuvet, turbidometric, linear detection range 0.096 mg/dL to 11.5 mg/dL. Procedure: 5 min....
... 0.5-10 Kb RNA Ladder is suitable for sizing ... in glyoxal or formaldehyde agarose gels. The ladder consists ... 2 3 4 6 8 and 10 kb) to ... intense than the other bands allowing easy orientation and ...
Recombinant Mouse Wnt-3a...
Homo sapiens jumping translocation breakpoint...
Biology Products: